Zacks Research Has Positive View of Docusign FY2027 Earnings

Docusign Inc. (NASDAQ:DOCU) – Equities researchers at Zacks Research increased their FY2027 earnings estimates for Docusign in a research note issued to investors on Thursday, September 24th. Zacks Research analyst Team now expects that the company will earn $1.96 per share for the year, up from their previous estimate of $1.69. The consensus estimate for Docusign’s current full-year earnings is $2.13 per share. Zacks Research also issued estimates for Docusign’s Q1 2028 earnings at $0.49 EPS, Q2 2028 earnings at $0.49 EPS, Q3 2028 earnings at $0.51 EPS, Q4 2028 earnings at $0.57 EPS, FY2028 earnings at $2.07 EPS, Q1 2029 earnings at $0.66 EPS, Q2 2029 earnings at $0.67 EPS and FY2029 earnings at $1.95 EPS.

Docusign (NASDAQ:DOCU) last issued its quarterly earnings results on Thursday, September 3rd. The company reported $1.16 EPS for the quarter, topping analysts’ consensus estimates of $1.09 by $0.07. The firm had revenue of $875.75 million for the quarter, compared to analyst estimates of $867.22 million. Docusign had a net margin of 9.82% and a return on equity of 18.29%. The business’s revenue for the quarter was up 9.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.30 EPS.

A number of other research firms also recently weighed in on DOCU. Needham & Company LLC restated a “hold” rating on shares of Docusign in a research report on Friday, September 4th. UBS Group boosted their target price on Docusign from $54.00 to $70.00 and gave the stock a “neutral” rating in a research report on Friday, September 4th. Wedbush cut their target price on Docusign from $60.00 to $58.00 and set a “neutral” rating for the company in a research note on Friday, June 5th. Wall Street Zen cut shares of Docusign from a “strong-buy” rating to a “buy” rating in a research report on Sunday, August 2nd. Finally, BTIG Research lifted their price target on shares of Docusign from $60.00 to $75.00 and gave the stock a “buy” rating in a research note on Wednesday, September 2nd. Three research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $67.33.

Docusign Stock Performance

Shares of NASDAQ:DOCU opened at $67.15 on Tuesday. Docusign has a 52-week low of $40.16 and a 52-week high of $75.00. The firm has a fifty day moving average of $62.70 and a 200 day moving average of $52.71. The firm has a market capitalization of $12.55 billion, a PE ratio of 40.95, a price-to-earnings-growth ratio of 2.48 and a beta of 0.90.

Insider Buying and Selling

In other Docusign news, Director Mary Wilderotter sold 1,096 shares of the business’s stock in a transaction that occurred on Wednesday, September 16th. The stock was sold at an average price of $70.60, for a total value of $77,377.60. Following the completion of the sale, the director owned 3,199 shares in the company, valued at approximately $225,849.40. The trade was a 25.52% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Robert Chatwani sold 14,676 shares of the stock in a transaction that occurred on Thursday, September 17th. The shares were sold at an average price of $69.41, for a total value of $1,018,661.16. Following the sale, the insider directly owned 75,928 shares of the company’s stock, valued at approximately $5,270,162.48. This trade represents a 16.20% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 123,318 shares of company stock worth $8,181,555 in the last 90 days. 0.59% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Docusign

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in DOCU. Modus Advisors LLC bought a new stake in Docusign in the 4th quarter worth $27,000. WealthCollab LLC raised its stake in shares of Docusign by 372.4% during the first quarter. WealthCollab LLC now owns 855 shares of the company’s stock valued at $41,000 after acquiring an additional 674 shares during the last quarter. Virtus Advisers LLC purchased a new stake in shares of Docusign during the second quarter worth about $47,000. Rakuten Securities Inc. purchased a new stake in shares of Docusign during the second quarter worth about $49,000. Finally, Harbour Investments Inc. grew its stake in shares of Docusign by 56.6% in the fourth quarter. Harbour Investments Inc. now owns 797 shares of the company’s stock worth $55,000 after purchasing an additional 288 shares during the last quarter. 77.64% of the stock is currently owned by institutional investors.

More Docusign News

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Raised long-term earnings outlook: Zacks Research increased its FY2027 EPS estimate to $1.96 from $1.69, FY2028 to $2.07 from $1.76, and FY2029 to $1.95 from $1.35. The upgrades suggest analysts see stronger profitability and sustained operating leverage ahead. Docusign Stock Earnings Estimates Lifted by Zacks Research
• Positive Sentiment: Several quarterly estimates were raised: Zacks lifted its Q1 2028 EPS forecast to $0.49 from $0.47, Q2 2028 to $0.49 from $0.28, Q3 2028 to $0.51 from $0.38, and Q2 2029 to $0.67 from $0.21. These revisions reinforce the bullish earnings narrative.
• Positive Sentiment: Cash flow and capital returns remain supportive: The company’s strong cash generation could fund margin expansion and additional buybacks, potentially supporting per-share earnings and valuation.
• Neutral Sentiment: Estimates remain mixed: Zacks maintained its current full-year consensus reference near $2.10–$2.13 EPS, while some longer-dated quarterly forecasts were revised upward. This indicates optimism is focused primarily on future profitability rather than a major near-term earnings reset.
• Negative Sentiment: Some forecasts were reduced: Zacks cut its Q1 2029 EPS estimate to $0.66 from $0.73 and Q4 2028 to $0.57 from $0.62. These isolated downgrades may temper enthusiasm, although they are outweighed by the broader upward revisions.

About Docusign

DocuSign, Inc (NASDAQ:DOCU) provides cloud-based software for electronically signing, managing and automating agreements. Its platform enables individuals and organizations to prepare, send, sign, track and store documents digitally, helping replace paper-based contracting processes.

The company’s offerings include electronic signature tools, contract lifecycle management, identity verification and authentication services, document generation, agreement analytics and related workflow automation capabilities.